In this study we found that pharmacologic inhibition of HDAC6 with tubacin restores endothelial-dependent relaxation, prevents the development of vascular stiffness—one of the integrated measures of vascular health in vivo—and significantly reduces plaque burden in a mouse model of atherosclerosis. This evidence concerns the gene HDAC6 and atherosclerosis.